Evidence map›Paper›PMID 39232049›Full record

ArticleScientific reports2024

Acute kidney injury as a prognostic marker in severe fever with thrombocytopenia syndrome.

Jin Mi Lee, Hae Lee Kim, Myoung-Nam Lim, Changhyup Kim, Yeon Ju La, Yong Duk Jeon, Won Sup Oh, Seongmin Son, Sunhwa Lee, Hyunjeong Baek and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jin Mi Lee *Department of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, 156, Baengnyeong-Ro, Chuncheon-Si, Chuncheon, Gangwon-Do, 24289, Republic of Korea.
Hae Lee Kim *Department of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, 156, Baengnyeong-Ro, Chuncheon-Si, Chuncheon, Gangwon-Do, 24289, Republic of Korea.
Myoung-Nam LimBiomedical Research Institute, Kangwon National University Hospital, Chuncheon, Gangwon-Do, South Korea.
Changhyup KimDepartment of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, 156, Baengnyeong-Ro, Chuncheon-Si, Chuncheon, Gangwon-Do, 24289, Republic of Korea.
Yeon Ju LaDepartment of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, 156, Baengnyeong-Ro, Chuncheon-Si, Chuncheon, Gangwon-Do, 24289, Republic of Korea.
Yong Duk JeonDepartment of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, 156, Baengnyeong-Ro, Chuncheon-Si, Chuncheon, Gangwon-Do, 24289, Republic of Korea.
Won Sup OhDepartment of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, 156, Baengnyeong-Ro, Chuncheon-Si, Chuncheon, Gangwon-Do, 24289, Republic of Korea.
Seongmin SonDepartment of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, 156, Baengnyeong-Ro, Chuncheon-Si, Chuncheon, Gangwon-Do, 24289, Republic of Korea.
Sunhwa LeeDepartment of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, 156, Baengnyeong-Ro, Chuncheon-Si, Chuncheon, Gangwon-Do, 24289, Republic of Korea.
Hyunjeong BaekDepartment of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, 156, Baengnyeong-Ro, Chuncheon-Si, Chuncheon, Gangwon-Do, 24289, Republic of Korea.
Daniel Duck-Jin HwangDepartment of Ophthalmology, Hangil Eye Hospital, Incheon, South Korea.
Ji In ParkDepartment of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, 156, Baengnyeong-Ro, Chuncheon-Si, Chuncheon, Gangwon-Do, 24289, Republic of Korea. park.jiin@gmail.com.

Funding

National Research Foundation of Korea 2022R1F1A1074063
6 · The paper itself

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne illness with a notable morality risk that is becoming increasingly prevalent in East Asia (14-36%). Increasing evidence indicates a more direct role of the SFTS virus in renal impairment. However, few studies have explored the risk factors for and clinical outcomes of AKI in patients with SFTS. Therefore, in this study, we aimed to investigate risk factors and outcomes associated with AKI in patients with SFTS. In this retrospective cohort study, we included the data of 53 patients who were diagnosed with SFTS virus infection at Kangwon National University Hospital between 2016 and 2020. We incorporated laboratory data and medical information including comorbidities, complications, and mortality. Baseline characteristics, clinical features, laboratory parameters, and mortality rates of the non-AKI and AKI groups were compared. Patient survival of non-AKI and AKI groups were compared using the Kaplan-Meier method. To identify the population with poor prognosis, Cox regression analysis was used to identify the independent risk factors for in-hospital mortality in patients with SFTS. Of the 53 individuals, 29 (54.7%) were male, with an average age of 66.5 years. Nine patients (15.1%) died of SFTS. Twenty-seven (50.9%) patients exhibited AKI; the average time interval from fever onset to AKI occurrence was 3.6 days. Notably, 24 (88.9%) patients developed AKI within the first week of fever onset. Patients in the AKI group exhibited a significantly higher prevalence of diabetes and were older than those in the non-AKI group. The mortality rate was notably higher (29.6%) in the AKI group than in the non-AKI group (3.8%). Within the AKI cohort, advanced stages (stages 2 and 3) showed a 50% mortality rate, which was significantly higher than the 17.6% mortality rate in patients with stage 1 AKI. Additionally, Kaplan-Meier curves revealed lower survival rates among patients with AKI than among those without AKI (P = 0.017). Cox regression analysis identified leukopenia and elevated serum creatinine levels as significant risk factors for mortality. AKI is a common complication associated with SFTS. Moreover, the mortality rate was significantly higher in the patients who developed AKI than in those who did not. Our findings underscore the pivotal role of AKI as a prognostic marker of disease severity in patients with SFTS.

Indexed as

Acute Kidney InjurySevere Fever with Thrombocytopenia SyndromeAgedAged, 80 and overBiomarkersFemaleHospital MortalityHumansMaleMiddle AgedPhlebovirusPrognosisRetrospective StudiesRisk FactorsBiomarkersAcute kidney injuryMortalityRisk factorsSevere fever with thrombocytopenia syndrome

Identifiers

PMID39232049
PMCPMC11374777

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.